Company Overview

Company name: Breath of Life (Israel)
Description: Manufacturer of cannabinoid based API and pharmaceutical products. The company’s products include cosmetics, clinical trials, medical cannabis and related produucts, enabling the pharmaceutical industry to access wide variety of products for their operation.
Year founded: 2008
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Revadim
Country: Israel
Region: Middle East

Financial Highlights

Start up capital raised (USD Million): 27.00
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company received $27 million of development capital from Amir Marketing & Investments In Agriculture on March 28, 2018, through a private placement. The investment will provide the acquirer with an advantage over other cannabis companies in the Israeli market.
Number of active investors:
Profile last updated: 26-Sep-2018
Last known valuation:
Last known valuation date: